Moreno-Garcia Alonso, Rodriguez-Merchan E Carlos
Department of Orthopedic Surgery, La Paz University Hospital, Madrid, Spain.
Arch Bone Jt Surg. 2022 Jul;10(7):536-542. doi: 10.22038/ABJS.2021.52770.2614.
Orthobiologics are organic and synthetic materials that help in the cure of musculo-skeletal problems and are utilized in Orthopaedic Surgery, both in and out of the surgical theater, to augment the possibilities of curing bone and soft tissue lesions. Taking into account that their effect is frequently multifactorial and, in some occasions not entirely comprehended, together with the insufficient clinical information, orthobiologics should be scrupulously assessed against other secure and clinically accepted options. The fundamental orthobiologics today ready for use in Orthopedic Surgery are the following: osseous hollow fillers, extracellular matrix (ECM) substances, platelet-rich plasma (PRP), bone morphogenetic protein-2 (BMP-2), bone marrow aspirate (BMA), bone marrow aspirate concentrate (BMAC), and mesenchymal stem cells (MSCs). It is predictable that in the time to come we will have more secure and more efficacious orthobiologics. Meanwhile, it is paramount that orthopedic surgeons have appropriate information of contemporary orthobiologics (biological adjuvants) so that they can utilize them correctly.
骨科生物制剂是有助于治疗肌肉骨骼问题的有机和合成材料,在骨科手术中,无论手术室内外,都可用于增加治愈骨和软组织损伤的可能性。鉴于其作用通常是多因素的,且在某些情况下尚未完全被理解,再加上临床信息不足,应将骨科生物制剂与其他安全且临床认可的选择进行严格评估。目前可用于骨科手术的基本骨科生物制剂如下:骨空心填充物、细胞外基质(ECM)物质、富血小板血浆(PRP)、骨形态发生蛋白-2(BMP-2)、骨髓抽吸物(BMA)、骨髓抽吸物浓缩物(BMAC)和间充质干细胞(MSCs)。可以预见,在未来我们将拥有更安全、更有效的骨科生物制剂。与此同时,至关重要的是骨科医生要掌握当代骨科生物制剂(生物佐剂)的适当信息,以便他们能够正确使用这些制剂。